A novel method employing genetic barcoding has been developed to track cancer cell adaptation and resistance evolution under drug pressure dynamically. This technique enables the precise quantification of phenotypic changes and clonal expansions in tumor populations, revealing that resistance arises through diverse cellular mechanisms beyond pre-existing clones. Published in Nature Communications, this approach offers a powerful tool for developing strategies to anticipate and counteract drug resistance, improving cancer treatment durability.